The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients

Clinical Infectious Diseases

Volumn 44, Issue 3, 2007, Pages 431-437

  McGovern, Barbara H ^a,b   Golan, Yoav ^a   Lopez, Marvin ^a   Pratt, Daniel ^a   Lawton, Angela ^a   Moore, Grayson ^a   Epstein, Mark ^a   Knox, Tamsin A ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COMORBIDITY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LIVER CIRRHOSIS; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; SERODIAGNOSIS; SPLENOMEGALY; THROMBOCYTOPENIA;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION, PORTAL; LEUKOCYTE COUNT; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SPLENOMEGALY;

EID: 33846460818     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/509580     Document Type: Article

References (33)

1. Benhamou Y, Bochet M, DiMartino V, Charlotte F, Azria F, Coutellier A. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 1999; 30:1054-8.
2. Martinez-Sierra C, Arizcorreta A, Diaz F, Roldan R. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 2003; 36:491-8.
3. Mohsen AH, Easterbrook PJ, Taylor C, et al. Impact of human immunodeficiency virus infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut 2003; 52:1035-40.
4. Di Martino V, Rufat P, Boyer N, et al. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 2001; 34:1193-9.
5. Rockstroh JK, Spengler U, Sudhop T, et al. Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. Am J Gastroenterol 1996; 91:2563-8.
6. Pol S, Artru P, Thepot V, Berthelot P, Nalpas B. Improvement of the CD4 cell count after alcohol withdrawal in HIV-positive alcoholic patients. AIDS 1996; 10:1293-4.
7. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Brit J Surg 1973; 60:646-9.
8. Mandy FF, Nicolson JK, McDougal JS. Guidelines for performing single-platform antibody CD4+ T-cell determinations with CD45 gating in persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003; 52(RR-2):1-13.
9. Scornik JC, Bray RA, Pollack MS, et al. Multicenter evaluation of the flow cytometry T-cell crossmatch: results from the American Society of Histocompatibility and Immunogenetics-College of American Pathologists proficiency testing program. Transplantation 1997; 63:1440-5.
10. Yeni PG, Hammer S, Hirsch M, et al. Treatment of adult HIV infection: 2004 recommendations of the International AIDS Society-USA panel. JAMA 2004; 292:251-65.
11. Bisset LR, Lung TL, Kaelin M, Ludwig E, Dubs RW. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland. Eur J Haematol 2004; 72:203-12.
12. Uppal SS, Verma S, Dhot PS. Normal values of CD4 and CD8 lymphocyte subsets in healthy Indian adults and the effects of sex, age, ethnicity, and smoking. Clinical Cytometry 2003; 52:32-6.
13. Tsegaye A, Mesele T, Tilahun T, et al. Immunohematological reference ranges for adult Ethiopians. Clin Diagn Lab Immunol 1999; 6:410-4.
14. Levin A, Brubaker G, Shao JS, et al. Determination of T-lymphocyte subsets on site in rural Tanzania: results in HIV-infected and non-infected individuals. Int J STD AIDS 1996; 7:288-91.
15. Menard D, Mandeng MJ, Tothy MB, Kelembho EK, Gresenguet G, Talarmin A. Immunohematological reference ranges for adults from the Central African Republic. Clin Diagn Lab Immunol 2003; 10:443-5.
16. Tugume SB, Piwowar EM, Lutalo T, et al. Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol 1995; 2: 233-5.
17. Kam KM, Leung WL, Kwok MY, Hung MY, Lee SS, Mak WP. Lymphocyte subpopulation reference ranges for monitoring human immunodeficiency vrius-infected Chinese adults. Clin Diagn Lab Immunol 1996; 3:326-30.
18. Urassa WK, Mbena EM, Swai AB, Gaines H, Mhalu FS, Biberfeld G. Lymphocyte subset enumeration in HIV seronegative and HIV-1 seropositive adults in Dar es Salaam, Tanzania: determination of reference values in males and females and comparison of two flow cytometric methods. J Immunol Methods. 2003; 277:65-74.
19. Yaman A, Cetiner S, Kibar F, Tasova Y, Seydaoglu G, Dundar IH. Reference ranges of lymphocyte subsets of healthy adults in Turkey. Med Princ Pract 2005; 14:189-93.
20. Chng WJ, Tan GB, Kuperan P. Establishment of adult peripheral blood lymphocyte subsets reference range for an Asian population by single-platform flow-cytometry: influence of age, sex and race and comparison with other published studies. Clin Diagn Lab Immunol 2004; 11: 168-73.
21. Jentsch-Ullrich K, Koenigsmann M, Mohren M, Franke A. Lymphocyte subsets' reference ranges in an age- and gender-balanced population of 100 heatlhy adults-a monocentric German study. Clin Immunol 2005; 116:192-7.
22. Bofil M, Janossy G, Lee C, et al. Laboratory control values for CD4 and CD8 T lymphocytes. Clin Exp Immunol 1992; 88:243-52.
23. Aina O, Dadik J, Charurat M, et al. Immunohematological reference ranges for adult Ethiopians. Clin Diagn Lab Immunol 2005; 12:525-30.
24. Giorgi JV, Cheng HL, Margolick J, Bauer KD, Ferbas J, Waxdal M. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the muticenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group. Clin Immunol Immunopathol 1990; 55: 173-86.
25. Eyster ME, Whitehurst DA, Catalano PM, et al. Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia. Blood 1985; 66:1317-20.
26. Sherman K, Rouster SD, Chung RT, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US Adult AIDS Clinical Trials Group. Clin Infect Dis 2002; 34:831-7.
27. Konopnicki D, Mocroft A, de Wit S, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005; 19: 593-601.
28. Miller M, Haley C, Koziel M, Rowley C. Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis. Clin Infect Dis 2005; 41:713.
29. Neff GW, Bonham A, Tzakis A, Ragni M. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transplantation 2003; 9:239-47.
30. 3. J Infect Dis 2005; 192:950-7.
31. Mulcahy F, Wallace E, Woods S, et al. CD4 counts in pregnancy do not accurately reflect the need for long-term HAART [abstract 704B]. In: Program and abstracts of the 13th Conference on Retroviruses and Opportunistic Infections (Denver, CO). Alexandria, VA: Foundation for Retrovirology and Human Health, 2006.
32. Puro V, Ippolito G. Effect of antiretroviral agents on T-lymphocyte subset counts in healthy HIV-negative individuals. J Acquir Immune Defic Syndr 2000; 24:440-3.
33. Centers for Disease Control and Prevention. Guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection. MMWR Recomm Rep 1992; 1(RR-8):1-17.